12/07/2018 23:02:49

Syneos Health Schedules Second Quarter 2018 Earnings Call for Thursday, August 2, 2018

RALEIGH, N.C., July 12, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and CCO (Contract Commercial Organization), will release its second quarter 2018 financial results on Thursday, August 2, 2018, prior to its earnings call at 8:00 a.m. ET. 

Participants may access the conference call live via webcast on the Investor Relations section of the Syneos Health website at investor.syneoshealth.com. To participate via telephone, please dial +1 877 930 8058 within the United States or +1 253 336 7551 outside the United States, approximately 15 minutes prior to the scheduled start time. The conference ID for the call is 2556819.

A webcast replay will be available on the Investor Relations section of the Syneos Health website at investor.syneoshealth.com after 1:00 p.m. on August 2. In addition, an audio replay will be available for one week following the call and will be accessible by dialing +1 855 859 2056 within the United States or +1 404 537 3406 outside the United States. The replay ID is 2556819.

About Syneos Health

Syneos Health™ (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life® visit syneoshealth.com.

Investor Relations Contact:                             

Ronnie Speight                                                    

Vice President, Investor Relations                       

+1 919 745 2745                                                  

investor.relations@syneoshealth.com                 

Press/Media Contact:

Danielle DeForge

Executive Director, External Communications

+1 781 425 2624

danielle.deforge@syneoshealth.com

Primary Logo

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
15 Jul
VWS
  Her i sommervarmen har jeg kigget lidt på Vestas kvartalsregnskaber og udviklingen i driftsmargine..
45
18 Jul
ZEAL
Baronen du er kandidat til stoerste selvfede narrehat herinde, uanset hvor mange gange du gentager d..
21
17 Jul
EI
Kære brugere   Som i har bemærket, er der igen til morgen problemer med vores streaming. Realtidskur..
17
16 Jul
DANSKE
Har du fået nej til en kassekredit nede i Danske Bank ?
17
17 Jul
VWS
MHI Vestas har nu øget sin ordrebeholdning til over 5GW, og der kommer meget mere endnu, og til næst..
16
17 Jul
 
USA har den svageste og mest retarderede præsident, som de nogensinde har haft.
14
19 Jul
GOOGL
Trump er uduelig og Putin benytter alle muligheder for at sætte splid internt i US og alle andre ste..
12
18 Jul
ZEAL
Ja, du har sagt og skrevet meget, og da det ikke er bedre end nedenfor, så har det ikke den store ef..
12
18 Jul
 
Dine reklamer afspejler din ageren på nettet. Tak dig selv for dine kinesiske reklamer
11
19 Jul
 
Hej Paknet. Æhæm, altså, hvordan skal jeg skære denne kage? Du ER tydeligvis ny på markedet, og der ..
10

HSBC Bank Plc : Form 8.5 (EPT/RI) - Lonmin PLC

22/02/2018 10:54:53
FORM 8.5 EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Name of exempt principal trader: HSBC BANK PLC (b) Name of offeror/offeree i..

Rathbone Brothers Plc : Preliminary announcement of 2017 results

22/02/2018 07:00:19
Funds under management up 14.3% to £39.1 billionThis is a preliminary statement of annual results published in accordance with FCA Listing Rule 9.7A. It covers the year ended 31 December 2017. Mark Nicholls, Chairman of Rathbone Brothers Plc, said: "UK and global investment markets performed well in 2017, with some indices reaching record levels towards the end of the year. This outcome has b..

Elliott Capital Advisors, L.P : Form 8.3 - GKN Plc

Related news
21/02/2018 15:25:10
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Elliott Capital Advisors, L.P. (for itself and related general partners ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Second quarter 2018 results - ramping up construction and increasing backlog and pipeline
2
Pittsburgh International Airport Selects World-Renowned Architectural and Engineering Firms with Local Ties to Collaborate on Design of New Terminal
3
Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against National Beverage Corp.
4
Sterling National Bank Grows Commercial Banking and Commercial Finance Teams with Key Hires
5
FAURECIA : DOUBLE-DIGIT GROWTH IN SALES AND OPERATING INCOME IN THE FIRST HALF - UPGRADED FULL-YEAR GUIDANCE

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
21 July 2018 04:25:58
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180712.1 - EUROWEB2 - 2018-07-21 05:25:58 - 2018-07-21 04:25:58 - 1000 - Website: OKAY